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Objective: To determine the association of long term sodium valproate monotherapy and vitamin D3 levels in 
epileptic children 
 
Materials and Methods: This cross-sectional study was conducted in the Department of Paediatrics, Children 
Hospital, Pakistan Institute of Medical Sciences, Islamabad for six months from 15th February 2019 to 14th August 
2019. A total of one hundred and thirty (n=130) children and adolescents of either gender between age 3-18 years 
who had a history of two seizures at least 24 hours apart in their life and were on sodium valproate monotherapy 
for more than one year were enrolled in this study through non-probability, consecutive sampling. Serum vitamin 
D3 (25-hydroxy vitamin D) levels were measured in all the patients at the time of enrolment into the study. All the 
demographic data and laboratory investigations were entered on the predesigned proforma and analyzed 
through SPSS version 17. 
 
Results: Vitamin D3 deficiency was found in 47 (36.2%) children which were significantly higher among patients 
with older age and longer duration of treatment (P<0.05) while gender and BMI of the patients did not show any 
significant difference (P>0.05). 
 
Conclusion: Significant percentage of epileptic children on sodium valproate monotherapy was found to have 
vitamin D3 deficiency. Therefore we recommend routine screening of vitamin D3 deficiency in all the epileptic 
children on long-term sodium valproate therapy followed by vitamin D supplementation in deficient patients. 
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Introduction 
 
Epilepsy is the most common neurological disease 
affecting 50 million people of all ages throughout the 
world.1 Out of these, 85% live in developing 
countries.1 In the United States and Europe the 
prevalence of epilepsy is 6.8 and 5.5 per 1000 
population respectively.2 
The prevalence of epilepsy in urban and rural areas of 
Pakistan is 7.4 and 14.8 per 1000 respectively with an 
overall average prevalence of 9.99 per 1000 
population.3 Prevalence of childhood and adolescent 
epilepsy under 16 years of age in Pakistan is 7 per 1000 
population with equal distribution in urban and rural 
areas.4 Almost 50% of patients develop epilepsy in 
their childhood.5 In Pakistan, only 34% patients of with 
epilepsy are managed properly by qualified doctors 
with anti-epileptic drugs (AEDs). The rest of the 
patients are treated by paramedics and faith healers.4 
Sodium valproate is one of the commonly used AEDs 
in the world. The majority of AEDs are inducers of 
hepatic cytochrome P450 isoenzymes which decrease 
the level of vitamin D3 (25-hydroxy vitamin D) in the 
body due to its rapid metabolism in the liver.6 But 
sodium valproate is not an inducer of hepatic 
cytochrome P450 isoenzymes but still results in a low 
level of vitamin D3 in the body due to inhibition of 25-
hydroxylation of vitamin D in liver mitochondria.7 
Childhood is the most commonly affected age group in 
epilepsy which is the most critical period for growth 
and development. A low level of vitamin D3 in the 
body at this age results in short stature due to its effect 
of reduced bone mineral density. Reduced bone 
mineral density is also one of the factors responsible 
for increased frequency of fractures in epileptic 
patients.8 Low levels of vitamin D3 in the body result 
in aggravation of seizures as it down-regulates 
cytokine IL-6, which is a proconvulsant.9 Consequently 
many treating physicians increase the dose of AEDs to 
control the seizures which further aggravates 
deficiency of vitamin D3 in the body and this vicious 
circle continues. 
In epileptic patients, vitamin D3 deficiency and 
reduced bone mineral density also result from other 
factors like malnutrition, decrease physical activity 
and reduce sunshine exposure which confuses the 
actual association of sodium valproate and vitamin D3 
deficiency. This led the scientists to investigate this 
matter in different geographical areas of the world 
with varying sunshine exposure and dietary habits of 
patients which shows different results.6,10 
Literature research revealed only one study from 
Pakistan which was done on 26 epileptic children to 
look for the effect of sodium valproate monotherapy 
for at least 3 months on vitamin D3 levels.11 No such 
study in Pakistan done so far on epileptic children 
taking sodium valproate monotherapy for more than 
one year. Therefore, this study was conducted on a 
large sample size to determine the association of long-
term sodium valproate monotherapy and vitamin D3 
levels in epileptic children.  
 
Materials and Methods 
 
After seeking permission from the research and ethics 
committee of Pakistan Institute of Medical Sciences 
(PIMS), Islamabad, this cross-sectional study was 
conducted in the Paediatric department of, Children 
Hospital, Pakistan Institute of Medical Sciences, 
Islamabad. Patients from 3 to 18 years of age of either 
gender with a history of two seizures at least 24 hours 
apart in their life and who were on sodium valproate 
monotherapy for more than one year were included in 
this study. Patients receiving vitamin D supplements, 
taking two or more AEDs, having any other systemic 
disease or neurological deficit were excluded from this 
study. 
Total 130 patients were taken as a sample size by using 
the WHO sample size calculator with the following 
values of calculations; 95% confidence level, 
anticipated population proportion=31.1%5, and 
absolute precision required=8%.  
All the patients who fulfilled the inclusion criteria 
were recruited through non-probability, consecutive 
sampling & written informed consent was obtained 
from parents/guardians before enrollment in the 
study. Vitamin D3 levels (25-hydroxy vitamin D) were 
measured through the radioimmunoassay technique 
with the Diasorin SR kit by LIASON in all the patients 
from the hospital’s laboratory free of cost. Patients 
were considered vitamin D3 deficient if its level is < 20 
ng/ml. All the demographic data, height, weight, BMI, 
and laboratory investigations were entered on the 
predesigned proforma.  
The data was then entered and analyzed using SPSS 
version 17. Mean ± SD was calculated for quantitative 
variables like age, body mass index (BMI), and serum 
vitamin D3 levels. Frequencies and percentages were 
calculated for qualitative variables like gender and 
vitamin D3 deficiency.  Effect modifiers like age, 
gender, BMI, and duration of treatment before 
checking vitamin D levels were stratified.  Post-
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stratification chi-square test was applied and P-value ≤ 




In this study, a total of 130 children was enrolled out 
of which 47 (36.2%) were found to have vitamin D3 
deficiency. Characteristics of patients are shown in 
Table 1. 
The deficiency of vitamin D3 was significantly higher 
among patients with older age and longer duration of 
treatment (P<0.05) while gender and BMI did not 
show any significant difference (P>0.05) as shown in 
Table 2. 
Table 1: Characteristics of patients 
Characteristics Mean + SD 
Age (years) 8.4 + 4.2 
BMI (Kg/m2) 17.7 + 2.7 
Duration of treatment (years) 4.9 + 2.6 
Vitamin D3 levels (ng/ml) 27.2 + 12.9 
Variables n (%) 
Gender 
   Male  58 (44.6%) 
   Female  72 (55.4%) 
Vitamin D3 Deficiency 
   Present 47 (36.2%) 
   Absent 83 (63.8%) 
 
Table 2: Comparison of vitamin D3 deficiency with patient’s age, gender, duration of treatment, and BMI 
Variables Vitamin D3 Deficiency Total P-Value 
Chi-Square 
  Present (%) Absent (%)   
Age 3-10 years 22 (26) 63 (74) 85 0.001 
  >10-18 years 25 (55.6) 20 (44.4) 45 
Gender Males 22 (38) 36 (62) 58 0.705 
  Females 25 (35) 47 (65) 72 
Duration of treatment < 5 Years 13 (17) 64 (83) 77 0.001 
  > 5 Years 34 (64) 19(36) 53 
BMI Normal 
Weight 
35 (37) 60 (63) 95 0.788 




In recent years, the importance of vitamin D3 has 
increased due to its role in increasing immunity and 
prevention of allergies and cancers. Therefore its 
deficiency in epileptic children has become even more 
important as seizures worsen during infections. Our 
study shows that 36.2% (n=47/130) of patients taking 
sodium valproate monotherapy have vitamin D3 
deficiency. This deficiency was found in higher 
parentages among older age children with a longer 
duration of treatment (P<0.05 in both cases) while 
gender and BMI of patients have no significant effect 
on vitamin D3 deficiency.  
Taha Abdullah et al carried out a study in Iraq on 50 
epileptic patients and 50 healthy children as control. 
Epileptic patients were 2 to 15 years old taking 
valproic acid for 6 months or more as monotherapy. 
They found a low level of vitamin D3 in 70% of 
patients as compared to 30% of healthy children. This 
study revealed almost 2 times more deficiency of 
vitamin D3 in epileptic children as compared to our 
study.6 
Sreedharan et al did their study in Kerala, India on 56 
epileptic patients, 2 to 13 years old, and 109 controls. 
Out of 56 patients, 28 were on sodium valproate 
monotherapy for at least 6 months and the other 28 
were on carbamazepine monotherapy. They found 
vitamin D3 deficiency in 36% (n=10/28) patients on 
sodium valproate monotherapy as compare to 28% 
(n=30/109) children in the control group which is 
exactly similar to the result of our study.12 
Chaudhuri et al conducted their study in Hyderabad 
India on 100 epileptic patients below 18 years of age 
and 50 controls. Out of 100 patients, 21 patients were 
on sodium valproate monotherapy for 12 months or 
more. They found vitamin D3 deficiency in 31.1% of 
patients taking sodium valproate monotherapy as 
compare to 24% in the control group which is slightly 
lower than that of our study.5 
Rafiq et al carried out a study in Rawalpindi, Pakistan 
on 34 epileptic children and 34 healthy controls. Out of 
34 patients, 26 were on sodium valproate 
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monotherapy and 8 were on carbamazepine 
monotherapy for more than 3 months. They found 
vitamin D3 deficiency in 32.4% of all patients 
(n=11/34) as compared to 5.9% (n=2/31) in the control 
group. This cannot be compared to the results of our 
study as a separate percentage of vitamin D3 deficient 
patients taking sodium valproate monotherapy is not 
mentioned.11 
Ginige et al conducted a retrospective study on 119 
epileptic children of Sri Lanka taking AEDs and 86 
healthy controls. Out of 119 epileptic patients, 27 were 
on sodium valproate monotherapy. Their results 
showed that 60.7% (n=17/27) of children taking 
sodium monotherapy were vitamin D3 deficient as 
compared to 45.3% of children in the control group. 
These results are 2 times higher than those of our 
study.13 
Razazizan et al conducted their study in Iran on 48 
ambulatory epileptic children, 2-14 years old, on AED 
monotherapy for at least 6 months and 48 healthy 
controls. Out of these 48 patients, only 9 patients were 
on sodium valproate monotherapy. They found a low 
level of vitamin D3 in 17% of all patients (n=8/48) as 
compare to 31% (n=15/48) controls. In this study, 
AEDs did not cause vitamin D3 deficiency which is 
contrary to all the above studies. We cannot compare 
our results with this study as well because the author 
did not mention a separate percentage of patients with 
vitamin D3 deficiency who were taking sodium 
valproate monotherapy.10 
Shellhaas et al found in their study that girls and 
children with high BMI are more at risk of vitamin D3 
deficiency which is different from the results of our 
study.14 
Kumar et al in their study show that the prevalence of 
vitamin D3 increases with the increase in the age of 
children which is consistent with our study.15 This may 
be due to the fact that older children spend more time 
indoors due to their educational commitments.16 
Some studies also found that vitamin D3 deficiency 
and low bone mineral density are significantly more 
common in patients with a long duration of treatment 
with sodium valproate.5,17 This finding is similar to 
that of our study.  
Our study has some limitations. We didn’t include 
patient’s diet, activities, and sunshine exposure in our 
study which can affect their vitamin D3 levels. We did 
not check vitamin D3 levels in healthy control children. 
We also did not check the patient’s serum calcium 
levels and bone mineral densities due to financial 
constraints.  
In summary, the results of the majority of the above-
cited studies indicate that vitamin D3 deficiency was 
found in a significant percentage of epileptic children 
on sodium valproate monotherapy which can result in 
a variety of health issues in them. We, therefore, 
recommend routine screening of vitamin D3deficiency 
in all epileptic children taking sodium valproate 
therapy. Further studies should be done to determine 
the minimum dose of vitamin D supplementation 





Our study shows that a significant percentage of 
epileptic children on sodium valproate monotherapy 
have vitamin D3 deficiency which is higher among 
older age children with a longer duration of treatment. 
Therefore we recommend routine screening of vitamin 
D3 deficiency in all epileptic children on long-term 
sodium valproate therapy followed by vitamin D 
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